Cargando…

Are Genetic Vaccines the Right Weapon against COVID-19?

Detalles Bibliográficos
Autores principales:	Conforti, Antonella, Marra, Emanuele, Roscilli, Giuseppe, Palombo, Fabio, Ciliberto, Gennaro, Aurisicchio, Luigi
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	American Society of Gene & Cell Therapy 2020
Materias:	Letters to the Editor
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7283060/ https://www.ncbi.nlm.nih.gov/pubmed/32553431 http://dx.doi.org/10.1016/j.ymthe.2020.06.007

Ejemplares similares

The promise of anti-ErbB3 monoclonals as new cancer therapeutics
por: Aurisicchio, Luigi, et al.
Publicado: (2012)

The perfect personalized cancer therapy: cancer vaccines against neoantigens
por: Aurisicchio, Luigi, et al.
Publicado: (2018)

SARS-CoV-2 SPIKE PROTEIN: an optimal immunological target for vaccines
por: Salvatori, Giovanni, et al.
Publicado: (2020)

Neoantigen cancer vaccine augments anti-CTLA-4 efficacy
por: Salvatori, Erika, et al.
Publicado: (2022)

Safety and efficacy of a genetic vaccine targeting Telomerase plus chemotherapy for the therapy of canine B-cell lymphoma
por: Gavazza, Alessandra, et al.
Publicado: (2013)

Emerging Cancer Vaccines: The Promise of Genetic Vectors
por: Aurisicchio, Luigi, et al.
Publicado: (2011)

Poly-specific neoantigen-targeted cancer vaccines delay patient derived tumor growth
por: Aurisicchio, Luigi, et al.
Publicado: (2019)

ErbB3 plays a key role in the early phase of establishment of resistance to BRAF and/or MEK inhibitors
por: Fattore, Luigi, et al.
Publicado: (2015)

Immunogenicity of COVID-eVax Delivered by Electroporation Is Moderately Impacted by Temperature and Molecular Isoforms
por: D’Alessio, Federico, et al.
Publicado: (2023)

Antitumor efficacy of a neoantigen cancer vaccine delivered by electroporation is influenced by microbiota composition
por: Lione, Lucia, et al.
Publicado: (2021)

Circulating MMP11 and specific antibody immune response in breast and prostate cancer patients
por: Roscilli, Giuseppe, et al.
Publicado: (2014)

Design of a companion bioinformatic tool to detect the emergence and geographical distribution of SARS-CoV-2 Spike protein genetic variants
por: Massacci, Alice, et al.
Publicado: (2020)

A first-in-human trial on the safety and immunogenicity of COVID-eVax, a cellular response-skewed DNA vaccine against COVID-19
por: Aurisicchio, Luigi, et al.
Publicado: (2023)

Synergistic antitumor activity of histone deacetylase inhibitors and anti-ErbB3 antibody in NSCLC primary cultures via modulation of ErbB receptors expression
por: Ciardiello, Chiara, et al.
Publicado: (2016)

Antibody-drug conjugates: smart weapons against cancer
por: Hayat, Seyed Mohammad Gheibi, et al.
Publicado: (2019)

Is photodynamic therapy a viable antiviral weapon against COVID-19 in dentistry?
por: Joseph, Betsy, et al.
Publicado: (2021)

Combination therapy with anti-ErbB3 monoclonal antibodies and EGFR TKIs potently inhibits Non-small Cell Lung Cancer
por: Noto, Alessia, et al.
Publicado: (2013)

Combination of antibodies directed against different ErbB3 surface epitopes prevents the establishment of resistance to BRAF/MEK inhibitors in melanoma
por: Fattore, Luigi, et al.
Publicado: (2015)

Fenofibrates: A Safe and Novel Weapon Against Coronavirus-Induced Lung Fibrosis
por: Namazi, Mohammad Reza, et al.
Publicado: (2022)

Tel-eVax: a genetic vaccine targeting telomerase for treatment of canine lymphoma
por: Impellizeri, Joseph A., et al.
Publicado: (2018)

A novel minigene scaffold for therapeutic cancer vaccines
por: Aurisicchio, Luigi, et al.
Publicado: (2014)

Wolbachia: a possible weapon for controlling dengue in Nepal
por: Khadka, Sujan, et al.
Publicado: (2020)

Linear DNA amplicons as a novel cancer vaccine strategy
por: Conforti, Antonella, et al.
Publicado: (2022)

Could SARS-CoV-2 or COVID-19 Be a Biological Weapon?
por: DEHGHANI, Arezoo, et al.
Publicado: (2020)

Nurse-performed ultrasound: a new weapon against COVID-19
por: Sun, Jianhua, et al.
Publicado: (2020)

Genetic Vaccination as a Flexible Tool to Overcome the Immunological Complexity of Invasive Fungal Infections
por: Luberto, Laura, et al.
Publicado: (2021)

Preparing at the Local Level for Events Involving Weapons of Mass Destruction
por: Hoard, Marna L., et al.
Publicado: (2002)

A Lethal Cardiac Injury Inflicted by a Nonlethal Weapon
por: Gachabayov, Mahir, et al.
Publicado: (2019)

Implanted peripheral nerve stimulator – Another weapon for managing pain
por: Sahoo, Rajendra, et al.
Publicado: (2020)

Comment on: Risk factors for workplace encounters with weapons by hospital employees()
por: Okani, Chidinma, et al.
Publicado: (2022)

A linear DNA encoding the SARS-CoV-2 receptor binding domain elicits potent immune response and neutralizing antibodies in domestic cats
por: Conforti, Antonella, et al.
Publicado: (2023)

Immunonutrition in perioperative care of COVID-19 patients: an old weapon for a new disease?
por: Deana, Cristian
Publicado: (2021)

Nut Consumption and Lung Cancer Risk: Is Linoleic Acid the Secret Weapon?
por: Mormile, Raffaella
Publicado: (2020)

Safety, tolerability and immunogenicity of V934/V935 hTERT vaccination in cancer patients with selected solid tumors: a phase I study
por: Aurisicchio, Luigi, et al.
Publicado: (2020)

Electrical Weapons and Electrophysiology
por: Kroll, Mark W., et al.
Publicado: (2020)

Rhino-orbital-cerebral mucormycosis in COVID-19 patients – Taming the black evil with pharmacological weapons
por: Kaur, Kirandeep, et al.
Publicado: (2021)

Pericapsular nerve group (PENG) block for hip fractures: Another weapon in the armamentarium of anesthesiologists
por: Sahoo, Rajendra Kumar, et al.
Publicado: (2021)

Reply: Electrical Weapons and Electrophysiology
por: Barbhaiya, Chirag R., et al.
Publicado: (2020)

Activation of the ErbB3-AKT axis promotes melanoma cell survival and proliferation in response to RAF/MEK inhibition
por: Fattore, Luigi, et al.
Publicado: (2014)

Activation of an early feedback survival loop involving phospho-ErbB3 is a general response of melanoma cells to RAF/MEK inhibition and is abrogated by anti-ErbB3 antibodies
por: Fattore, Luigi, et al.
Publicado: (2013)

Cannot write session to /tmp/vufind_sessions/sess_ie1clf1b9a4bmjfp3lgf6blvl1